Found: 4
Select item for more details and to access through your institution.
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 738, doi. 10.1007/s10637-019-00768-6
- By:
- Publication type:
- Article
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 319, doi. 10.1007/s10637-016-0343-x
- By:
- Publication type:
- Article
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1246, doi. 10.1007/s10637-014-0151-0
- By:
- Publication type:
- Article
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-44
- By:
- Publication type:
- Article